News
DRTS
13.70
-2.91%
-0.41
Weekly Report: what happened at DRTS last week (1102-1106)?
Weekly Report · 1d ago
Alpha Tau Medical (DRTS) Climbed, So What Is Behind The Fresh Attention?
Simply Wall St · 5d ago
Alpha Tau Medical Stock Has The Bull Case Changed After Pancreatic Trial MOU
Simply Wall St · 6d ago
Weekly Report: what happened at DRTS last week (1026-1030)?
Weekly Report · 11/02 09:27
Alpha Tau to Join TASE Flagship TA-90 and TA-125 Indices in Early November
TipRanks · 10/29 16:47
Alpha Tau Medical To Join TASE’s TA-90 and TA-125 Indices On November 5, 2026
Benzinga · 10/29 16:18
Is Alpha Tau Medical (DRTS) Overvalued After FDA Approval Expanded Its REGAIN Trial?
Simply Wall St · 10/28 08:17
How Expanded Glioblastoma Trial Will Impact Alpha Tau Medical Stock (DRTS)
Simply Wall St · 10/27 06:20
Weekly Report: what happened at DRTS last week (1019-1023)?
Weekly Report · 10/26 09:26
Alpha Tau signs MOU with Samsung Medical Center in Seoul
TipRanks · 10/22 13:11
Alpha Tau Signs MOU with Samsung Medical Center for Pancreatic Cancer Trial in Korea
TipRanks · 10/22 12:57
Alpha Tau Medical Inks MoU With Samsung Medical Center In Seoul Regarding Potential Clinical Study In Pancreatic Cancer Patients
Benzinga · 10/22 12:32
Barclays Sticks to Their Buy Rating for Alpha Tau (DRTS)
TipRanks · 10/21 08:46
Alpha Tau Medical Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Dow Jones · 10/20 16:49
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target
Benzinga · 10/20 16:39
Yi Chen Reiterates Buy on Alpha Tau as FDA-Backed Trial Expansion and Pivotal ReSTART Study Support Unchanged $16 Price Target
TipRanks · 10/20 15:05
Alpha Tau Gains FDA Approval For REGAIN Trial Expansion In Recurrent Glioblastoma; Shares Rise
NASDAQ · 10/19 15:11
Alpha Tau Wins FDA Nod to Expand U.S. REGAIN Glioblastoma Trial, Data Heading to SNO 2026
TipRanks · 10/19 14:47
FDA Greenlights Expansion of Alpha Tau’s Brain Cancer Trial, With New Data Weeks Away (NASDAQ: DRTS)
TipRanks · 10/19 13:50
Alpha Tau announces FDA approval of REGAIN trial IDE supplement
TipRanks · 10/19 13:05
More
Webull provides a variety of real-time DRTS stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTS
Alpha Tau Medical Ltd is an Israel-based medical technology company engaged in the research, development, and commercialization of innovative cancer treatment technologies. The Company focuses on Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), a platform designed for the treatment of solid tumors through the localized delivery of alpha radiation within tumor tissue. Its technology utilizes radioactive radium-224 sources that release short-range alpha particles intended to damage and destroy cancer cells while limiting exposure to surrounding healthy tissue. The Company conducts activities related to product development, clinical studies, regulatory approval processes, and commercialization. Alpha Tau Medical Ltd serves the oncology sector and carries out its operations directly and through its subsidiary, Healthcare Capital Corp.